PL434201A1 - Hydrolysate of α- (1 → 3) -glucans isolated from the fruiting bodies of sulfuric gall Laetiporus sulphureus for use as an oligosaccharide prebiotic - Google Patents
Hydrolysate of α- (1 → 3) -glucans isolated from the fruiting bodies of sulfuric gall Laetiporus sulphureus for use as an oligosaccharide prebioticInfo
- Publication number
- PL434201A1 PL434201A1 PL434201A PL43420120A PL434201A1 PL 434201 A1 PL434201 A1 PL 434201A1 PL 434201 A PL434201 A PL 434201A PL 43420120 A PL43420120 A PL 43420120A PL 434201 A1 PL434201 A1 PL 434201A1
- Authority
- PL
- Poland
- Prior art keywords
- fruiting bodies
- isolated
- gall
- hydrolysate
- sulfuric
- Prior art date
Links
- 229920001503 Glucan Polymers 0.000 title abstract 2
- 240000005995 Laetiporus sulphureus Species 0.000 title abstract 2
- 235000007714 Laetiporus sulphureus Nutrition 0.000 title abstract 2
- 235000013406 prebiotics Nutrition 0.000 title abstract 2
- 239000000413 hydrolysate Substances 0.000 title 1
- 229920001542 oligosaccharide Polymers 0.000 title 1
- 150000002482 oligosaccharides Chemical class 0.000 title 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 241000186000 Bifidobacterium Species 0.000 abstract 1
- 241000186660 Lactobacillus Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000001847 bifidogenic effect Effects 0.000 abstract 1
- 210000000941 bile Anatomy 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 244000005709 gut microbiome Species 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 229940039696 lactobacillus Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000006116 polymerization reaction Methods 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Przedmiotem wynalazku jest hydrolizat α-(1 → 3)-glukanów wyizolowanych z owocników żółciaka siarkowego Laetiporus sulphureus, znajdujący zastosowanie jako prebiotyk dla ludzi i zwierząt wspomagający namnażanie i wzrost dobroczynnej mikroflory jelitowej, zaburzonej np. na skutek przebytej antybiotykoterapii, stresu lub nieprawidłowej diety. Hydrolizat według wynalazku, wyizolowany z powszechnie dostępnego o stosunkowo niskiej cennie surowca, zawiera mieszaninę α-(1 → 3)-glukooligosacharydów o stopniu polimeryzacji od 2 do 10 i jest substancją o wysokim stopniu bifidogennym, na przykład, w stosunku do bakterii mlekowych Bifidobacterium i Lactobacillus.The subject of the invention is the hydrolyzate of α- (1 → 3) -glucans isolated from the fruiting bodies of sulfurous bile Laetiporus sulphureus, used as a prebiotic for humans and animals supporting the multiplication and growth of beneficial intestinal microflora, disturbed e.g. as a result of antibiotic therapy, stress or improper diet. The hydrolyzate according to the invention, isolated from a widely available, relatively low-cost raw material, contains a mixture of α- (1 → 3) -gluccooligosaccharides with a degree of polymerization from 2 to 10 and is a substance with a high degree of bifidogenic, for example, against the lactic acid bacteria Bifidobacterium and Lactobacillus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL434201A PL241759B1 (en) | 2020-06-04 | 2020-06-04 | Hydrolysate of α- (1 → 3) -glucans isolated from the fruiting bodies of sulfuric gall Laetiporus sulphureus for use as an oligosaccharide prebiotic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL434201A PL241759B1 (en) | 2020-06-04 | 2020-06-04 | Hydrolysate of α- (1 → 3) -glucans isolated from the fruiting bodies of sulfuric gall Laetiporus sulphureus for use as an oligosaccharide prebiotic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL434201A1 true PL434201A1 (en) | 2021-12-06 |
| PL241759B1 PL241759B1 (en) | 2022-12-05 |
Family
ID=80002086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL434201A PL241759B1 (en) | 2020-06-04 | 2020-06-04 | Hydrolysate of α- (1 → 3) -glucans isolated from the fruiting bodies of sulfuric gall Laetiporus sulphureus for use as an oligosaccharide prebiotic |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL241759B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL445271A1 (en) * | 2023-06-16 | 2024-12-23 | Uniwersytet Marii Curie-Skłodowskiej w Lublinie | Oligosaccharide preparation obtained from the fruiting bodies of the sulfur gall beetle (Laetiporus sulphureus) for use in the prevention and control of nosema in bees |
-
2020
- 2020-06-04 PL PL434201A patent/PL241759B1/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL445271A1 (en) * | 2023-06-16 | 2024-12-23 | Uniwersytet Marii Curie-Skłodowskiej w Lublinie | Oligosaccharide preparation obtained from the fruiting bodies of the sulfur gall beetle (Laetiporus sulphureus) for use in the prevention and control of nosema in bees |
| PL248026B1 (en) * | 2023-06-16 | 2025-10-06 | Univ Marii Curie Sklodowskiej W Lublinie | Oligosaccharide preparation obtained from the fruiting bodies of the sulfur gall beetle (Laetiporus sulphureus) for use in prevention and control of nosema in bees |
Also Published As
| Publication number | Publication date |
|---|---|
| PL241759B1 (en) | 2022-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sugahara et al. | Differences between live and heat-killed bifidobacteria in the regulation of immune function and the intestinal environment | |
| Iqbal et al. | Probiotics and their beneficial effects against various diseases. | |
| Craft et al. | The human milk glycome as a defense against infectious diseases: rationale, challenges, and opportunities | |
| US8691213B2 (en) | Protein free formula | |
| US20160100617A1 (en) | Nutritional composition for promoting gut microbiota balance and health | |
| FI20010157A0 (en) | probiotic | |
| ATE407687T1 (en) | PROBIOTIC LACTIC ACID BACTERIA FOR THE TREATMENT OF BACTERIAL INFECTIONS RELATED TO SIDS | |
| CN109452370A (en) | A kind of student's formula milk and its preparation process | |
| JPS62500722A (en) | Microbiota colonization method | |
| PL434201A1 (en) | Hydrolysate of α- (1 → 3) -glucans isolated from the fruiting bodies of sulfuric gall Laetiporus sulphureus for use as an oligosaccharide prebiotic | |
| CN113925158A (en) | Method for preparing metazoan extract, product obtained by the method and its use for inhibiting biofilm formation and promoting intestinal health | |
| Xu et al. | Breastfeeding and infant gut microbiota: influence of bioactive components | |
| Hermes et al. | Influence of dietary ingredients on in vitro inflammatory response of intestinal porcine epithelial cells challenged by an enterotoxigenic Escherichia coli (K88) | |
| Shu et al. | Effects of prebiotics on antioxidant activity of goat milk fermented by Lactobacillus plantarum L60 | |
| Dock et al. | Probiotics enhance recovery from malnutrition and lessen colonic mucosal atrophy after short-term fasting in rats | |
| CN113784630A (en) | Prebiotic compositions and uses thereof | |
| Volstatova et al. | Milk digesta and milk protein fractions influence the adherence of Lactobacillus gasseri R and Lactobacillus casei FMP to human cultured cells | |
| Viaşu-Bolocan et al. | Probiotics and their immunomodulatory potential | |
| Wang et al. | Lactic acid bacteria and host immunity | |
| Sugiharto et al. | Prevention of enterotoxigenic Escherichia coli infections in pigs by dairy-based nutrition. | |
| Szymański et al. | Colonisation of the gastrointestinal tract by probiotic L. rhamnosus strains in acute diarrhoea in children | |
| Rajput et al. | Role of plant-derived prebiotic in modulation of human gut microflora: a review | |
| PH12022551123A1 (en) | Nutritional compositions for treating a clostridium difficile infection | |
| WO2021159068A8 (en) | Composition and method of using germinative compounds in probiotics for inflammation reduction in humans | |
| Mneimneh et al. | Role of probiotics in gastrointestinal diseases |